NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 324 filers reported holding NATERA INC in Q1 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,891,998 | +53.1% | 178,350 | +68.3% | 0.00% | +100.0% |
| Q2 2023 | $5,155,539 | -6.5% | 105,950 | +6.7% | 0.00% | -33.3% |
| Q1 2023 | $5,514,788 | +33.5% | 99,330 | -3.4% | 0.00% | +50.0% |
| Q4 2022 | $4,129,386 | +14.3% | 102,798 | +24.6% | 0.00% | 0.0% |
| Q3 2022 | $3,614,000 | +64.3% | 82,471 | +32.9% | 0.00% | +100.0% |
| Q2 2022 | $2,199,000 | -19.4% | 62,038 | -7.5% | 0.00% | 0.0% |
| Q1 2022 | $2,727,000 | -78.4% | 67,044 | -50.5% | 0.00% | -83.3% |
| Q4 2021 | $12,651,000 | -9.7% | 135,462 | +7.8% | 0.01% | -25.0% |
| Q3 2021 | $14,009,000 | +14.4% | 125,712 | +16.6% | 0.01% | +14.3% |
| Q2 2021 | $12,241,000 | +14.6% | 107,821 | +2.5% | 0.01% | 0.0% |
| Q1 2021 | $10,682,000 | +167.4% | 105,196 | +162.0% | 0.01% | +133.3% |
| Q4 2020 | $3,995,000 | +43.9% | 40,146 | +4.5% | 0.00% | +50.0% |
| Q3 2020 | $2,776,000 | +97.2% | 38,423 | +36.1% | 0.00% | +100.0% |
| Q2 2020 | $1,408,000 | +82.4% | 28,233 | +9.2% | 0.00% | 0.0% |
| Q1 2020 | $772,000 | -12.1% | 25,860 | -0.7% | 0.00% | 0.0% |
| Q4 2019 | $878,000 | +10.0% | 26,055 | +7.1% | 0.00% | 0.0% |
| Q3 2019 | $798,000 | +111.7% | 24,326 | +78.1% | 0.00% | – |
| Q2 2019 | $377,000 | – | 13,661 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
| Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
| Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
| Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
| Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
| Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
| BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
| PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
| RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |